➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Colorcon
Boehringer Ingelheim
Moodys
AstraZeneca
Mallinckrodt

Last Updated: January 19, 2021

DrugPatentWatch Database Preview

Litigation Details for ADAMAS PHARMA, LLC v. SANDOZ INC. (D.N.J. 2018)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

ADAMAS PHARMA, LLC v. SANDOZ INC. (D.N.J. 2018)

Docket   Start Trial Date Filed 2018-05-10
Court District Court, D. New Jersey Date Terminated 2020-01-05
Cause 15:1126 Patent Infringement Assigned To Brian R. Martinotti
Jury Demand None Referred To Tonianne J. Bongiovanni
Parties ADAMAS PHARMA, LLC; SANDOZ INC.
Patents 6,913,768; 6,919,373; 8,039,009; 8,058,291; 8,168,209; 8,173,708; 8,252,331; 8,283,379; 8,293,794; 8,329,752; 8,338,485; 8,338,486; 8,362,085; 8,389,578; 8,574,626; 8,580,858; 8,598,233; 8,741,343; 8,796,337; 8,889,740; 8,895,614; 8,895,615; 8,895,616; 8,895,617; 8,895,618; 9,867,791; 9,867,792; 9,867,793; 9,877,933
Attorneys CHARLES MICHAEL LIZZA; CHRISTINA LYNN SAVERIANO; ERIC I. ABRAHAM; ISAAC SAMUEL ASHKENAZI; SARAH ANN SULLIVAN; WILLIAM C. BATON
Firms Christina Lynn Saveriano; Eric I. Abraham; Paul Hastings LLP; Saul Ewing Arnstein & Lehr LLP; Yevgenia Shtilman Kleiner
Link to Docket External link to docket
Small Molecule Drugs cited in ADAMAS PHARMA, LLC v. SANDOZ INC.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for ADAMAS PHARMA, LLC v. SANDOZ INC. (D.N.J. 2018)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 1 Complaint between 200 mg and example, by U.S. Pat. No. 6,913,768, hereby incorporated by 400 mg per… 45 example, by U.S. Pat. No. 6,913,768, hereby incorporated by antagonist or the levodopa… example, by U.S. Pat. No. 6,913,768, hereby incorporated by antagonist or the levodopa…preferably between 200 example, by U.S. Pat. No. 6,913,768, hereby incorporated by mg and 600… 45 example, by U.S. Pat. No. 6,913,768, hereby incorporated by antagonist or the levodopa External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Merck
McKesson
Harvard Business School
AstraZeneca
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.